Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Farmers Insurance
AstraZeneca
US Department of Justice
Cipla
Argus Health
Colorcon
Boehringer Ingelheim
Chinese Patent Office

Generated: November 21, 2018

DrugPatentWatch Database Preview

Drug Master Files for: DILTIAZEM HYDROCHLORIDE

« Back to Dashboard


DILTIAZEM HYDROCHLORIDE Drug Master Files

DMF No. Status Type Submission Date Holder Subject
10381 I II 7/9/1993 MITSUBISHI TANABE PHARMA CORP DILTIAZEM HYDROCHLORIDE (PROCESS C)
10466 I II 6/2/1993 SUMITRA PHARMACEUTICALS AND CHEMICALS LTD DILTIAZEM HYDROCHLORIDE
11077 I II 9/9/1994 TANABE SEIYAKU CO LTD DILTIAZEM MALATE
11161 I II 10/24/1994 MERCK RESEARCH LABORATORIES DIV MERCK AND CO INC DILTIAZEM ER TABLETS
11170 I II 10/28/1994 MERCK RESEARCH LABORATORIES DIV MERCK AND CO INC ENALAPRIL MALEATE & DILTIAZEM ER TABLETS
11504 I II 5/11/1995 DR REDDYS LABORATORIES LTD DILTIAZEM HYDROCHLORIDE
12071 I II 8/2/1996 ORION CORP FERMION DILTIAZEM HCL PROCESS II
DMF No. Status Type Submission Date Holder Subject

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Chinese Patent Office
Colorcon
Medtronic
US Army
Moodys
Accenture
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.